Skip to content

Making high-quality stem cells available at industrial scale.

Cellcolabs produces mesenchymal stem cells (MSCs) through the Cellcolabs Protocol, our GMP-certified manufacturing system, supporting clinical research and global collaborations.

Order cellsPartner with us

Setting the global standard for stem cell manufacturing.

We are setting the global standard for stem cell manufacturing, creating the foundation for how advanced cell therapies can become everyday medicine.


Each vial of our bone marrow-derived mesenchymal stem cells is produced according to the Cellcolabs Protocol, a manufacturing process refined through more than 25 years of scientific research at Karolinska Institutet. From donor selection and cell expansion to quality control and batch release, every step is standardized, validated and designed to deliver consistent, pharmaceutical-grade quality. Manufactured in GMP facilities, every batch meets the same rigorous standards for safety, consistency and full traceability.

Our GMP-certified production

Our scientifically validated protocol

Partnerships
Psl-Alliance (1)
OA-Action-Alliance (1)
KI-Science-Park-1
MSC Research overview

Evolving science of stem cell research

Mesenchymal stem cells are being researched globally to prevent and treat a broad range of indications.
Explore research library
As seen in
Vector
Business_Insider_Logo 1
TechCrunch_logo 1
Sky_News_logo 1
sifted-logo 1

Excellence in every cell.

Potent and consistent

Cryopreserved at Passage 3 for optimal cellular capacities and potency.

Defined cell identity

Phenotyping confirms MSC markers (CD90, CD73, CD105), ensuring purity.

Genetically stable

Karyotyping verifies chromosomal integrity across passages.

Antibiotic-free and sterile

All batches undergo bacterial and mycoplasma testing.